Valneva SE (VALN)
NASDAQ: VALN · Real-Time Price · USD
5.41
+0.15 (2.85%)
Oct 26, 2026, 4:00 PM EDT - Market closed

Valneva SE Revenue

Valneva SE had revenue of 34.94M EUR in the quarter ending June 30, 2026, a decrease of -27.71%. This brings the company's total for the last twelve months to 142.94M, down -27.19% year-over-year. In the year 2025, Valneva SE had annual revenue of 174.66M with 3.00% growth.

Revenue (ttm)
142.94M EUR
Revenue Growth
-27.19%
P/S Ratio
3.14
Revenue / Employee
230,544 EUR
Employees
620
Market Cap
513.03M USD

Revenue Chart

* This company reports financials in EUR.

Revenue by Geography

  • United States 53.61M 30.7%
  • Canada 30.13M 17.2%
  • Germany 17.47M 10.0%
  • France 14.67M 8.4%
  • Nordics 13.90M 8.0%
  • Other Europe 13.88M 7.9%
  • United Kingdom 12.64M 7.2%
  • Other 18.37M 10.5%
Fiscal year ended Dec 31, 2025 See the full Valneva SE breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025174.66M5.08M3.00%
Dec 31, 2024169.58M15.87M10.32%
Dec 31, 2023153.71M-207.59M-57.46%
Dec 31, 2022361.30M13.22M3.80%
Dec 31, 2021348.09M237.76M215.52%
Dec 31, 2020110.32M-15.88M-12.58%
Dec 31, 2019126.20M13.16M11.64%
Dec 31, 2018113.04M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Arvinas316.70M
Phathom Pharmaceuticals239.66M
CytomX Therapeutics18.30M
Oculis Holding AG1.45M
Neurogene925.00K
Entera Bio42.00K
Revenue Rankings